MedPath

The Prediction of Preeclampsia/Toxemia in Twin Pregnancy

Conditions
Preeclampsia/Toxemia
Registration Number
NCT01255202
Lead Sponsor
Assaf-Harofeh Medical Center
Brief Summary

The purpose of this study is to finout whetere uterinae artery flow , PP13 and endogolin levels in the serum and kongo red in the urine can predict preeclamsia toxemia in twin pregnancies.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • a women with a vaiable twin pregnany
Exclusion Criteria
  • women with thrombophilya
  • women terated with anticoagolant
  • women with vascular disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Assaf Harofe Medical Center

🇮🇱

Zrifin, Israel

© Copyright 2025. All Rights Reserved by MedPath